title: Duplex quantitative Reverse-Transcriptase PCR for simultaneous assessment of drug activity against Leishmania intracellular amastigotes and their host cells.
abstract: Currently available drugs for treatment of Leishmania infections are highly toxic and drug resistance to first line therapies has been observed. New, safer and more effective drugs are urgently needed to improve clinical resolution of the disease and reduce the risks associated with it. High-throughput screening of new compounds against cultured promastigotes is easy to perform, but the results are poorly predictive of in vivo efficacy. Intra-macrophage amastigote models provide a better proxy of the clinically relevant stage of disease and should be routinely implemented in the search for new anti-leishmanial agents, despite being labor intensive. This study describes the use of a duplex quantitative Reverse-Transcriptase PCR (qRT-PCR) for assessment of drug activity against Leishmania intracellular amastigotes and their host cells. The assay simultaneously quantifies Leishmania 18S ribosomal RNA and the human β2-microglobulin (β-2M) mRNA, used for monitoring drug cytotoxicity and test performance. Accurate determination of parasite viability by the newly developed qRT-PCR was confirmed by parallel assessment of compound performance against standard microscopy. Highly reproducible anti-leishmanial activities were obtained with a set of structurally- and pharmacologically-diverse compounds, whose toxicity against host cells correlated with a low β-2M amplification. Sensitive and versatile, this duplex qRT-PCR offers a valuable tool for assessment of drug activities against Leishmania amastigotes and their host cells.
authors.affiliation: Royal Tropical Institute (KIT), Department of Biomedical Research, Parasitology Unit, Meibergdreef 39, Amsterdam 1105 AZ, The Netherlands.
authors.forename: Erika
authors.initials: E
authors.lastname: van den Bogaart
authors.affiliation: Royal Tropical Institute (KIT), Department of Biomedical Research, Parasitology Unit, Meibergdreef 39, Amsterdam 1105 AZ, The Netherlands.
authors.forename: Gerard J
authors.initials: GJ
authors.lastname: Schoone
authors.affiliation: Royal Tropical Institute (KIT), Department of Biomedical Research, Parasitology Unit, Meibergdreef 39, Amsterdam 1105 AZ, The Netherlands.
authors.forename: Emily R
authors.initials: ER
authors.lastname: Adams
authors.affiliation: Royal Tropical Institute (KIT), Department of Biomedical Research, Parasitology Unit, Meibergdreef 39, Amsterdam 1105 AZ, The Netherlands.
authors.forename: Henk D F H
authors.initials: HD
authors.lastname: Schallig
keywords: Cell viability; Drug screening; Leishmaniasis; Polymerase chain reaction